Nascent Biotech Inc. (NBIO): On March 31, 2021, the Company entered i...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Nascent Biotech Inc. (NBIO)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	763
Posts	61549
Boards Moderated	0
Alias Born	02/18/2010

Re: Aa5 post# 1608

Tuesday, 05/11/2021 8:14:16 AM

Tuesday, May 11, 2021 8:14:16 AM

On March 31, 2021, the Company entered into a license agreement with BioRay Pharmaceutical Co Ltd granting a license for commercialization of the Company’s antibody Pritumumab internationally excluding North and Central America. Under terms of the agreement, the Company will receive US $5,000,000 at various milestones commencing with the initial payment received on April 20, 2021 of US $1,000,000. An additional payments of $750,000 will be received upon enrollment of the 12th patient in the phase 1 clinical trial which has enrolled its first cohort. Upon approval for phase 2 clinical trials from the United States Food and Drug Administration, the Company will receive $2,500,000. When the phase 2 trials begin the balance of $750,000 will be received.

https://ih.advfn.com/stock-market/USOTC/nascent-biotech-qb-NBIO/stock-news/85073323/current-report-filing-8-k

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NBIO News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 07:56:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:46:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:45:51 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 07:06:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 01:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:47:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 07:22:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 07:21:48 PM

More NBIO News

InvestorsHub NewsWire

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow